Immediate adverse events to intravenous immunoglobulin in pediatric patients with inborn errors of immunity: A longitudinal study with a pre-infusion protocol

INTRODUCTION: Immunoglobulin represents the main therapy for patients with inborn errors of immunity (IEI) and it is a safe procedure, but adverse events (AEs) can occur with variable frequencies. OBJECTIVE: To evaluate the frequency of immediate AEs to intravenous immunoglobulin (IVIG) regular ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Thales Silva, Melo, Karina Mescouto, Valente, Cláudia França Cavalcante, Tavares, Fabíola Scancetti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244234/
https://www.ncbi.nlm.nih.gov/pubmed/36114118
http://dx.doi.org/10.1016/j.htct.2022.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244234/
https://www.ncbi.nlm.nih.gov/pubmed/36114118
http://dx.doi.org/10.1016/j.htct.2022.06.009

Ejemplares similares